Cholera Case Fatality Rate: What Pushes It Below 1%
- Tony Miller
- Aug 31
- 6 min read
WHO's benchmark is a cholera case fatality rate below 1% in treatment centres. Getting there takes two things at once: rehydration reaching severe cases within hours, and safe water stopping the next wave of infections. South Sudan reported 1.7% between January and August 2025.
What is the cholera case fatality rate, and what is the benchmark?
The case fatality rate is simply deaths divided by reported cases over a defined period, expressed as a percentage. The reference point every response is measured against comes from WHO: the case fatality rate in treatment centres should remain below 1%. That is a demanding but routinely achievable standard, because cholera is one of the few killers where the clinical answer is cheap, well understood and decades old.
Two caveats matter before anyone quotes a number. First, the sub-1% benchmark applies to treatment centres, meaning people who actually arrived at a facility. A national or outbreak-wide CFR counts community deaths as well, so the two figures are not measuring the same population and should not be compared as if they were. Second, the denominator is *reported* suspected cases, and reporting quality varies between counties and between weeks.
The scale behind those percentages is large. WHO estimates 1.3 to 4.0 million cases and 21,000 to 143,000 deaths worldwide each year, and in 2023 recorded 535,321 cases and 4,007 deaths reported from 45 countries. Between 1 January and 17 August 2025, 409,222 cholera and acute watery diarrhoea cases and 4,738 deaths were reported across 31 countries.
Why does South Sudan's rate sit above the benchmark?
Over the same period, South Sudan reported 71,825 suspected cases and 1,194 deaths, a case fatality rate of 1.7%, across 55 of 80 counties. That is above the benchmark, and WHO's own risk assessment explains why in one line: nearly 50% of reported deaths occur within communities before patients reach health facilities, with delays in accessing care contributing to elevated case fatality rates. Geographic barriers, insecurity and displacement are named as the drivers in Chad, South Sudan and Sudan.
Read that carefully, because it reframes the whole problem. The gap between 1.7% and 1% is not primarily a clinical failure inside cholera treatment centres. It is a distance-and-time failure outside them. Half the deaths happen before a clinician ever sees the patient. Any intervention that shortens the distance between a sick person and oral rehydration therapy is working directly on the number; anything that does not is working on it indirectly at best.
What does treatment access contribute?
Treatment access is what keeps an already-infected person alive, and nothing in a WASH catalogue substitutes for it. WHO's position is unambiguous: most people can be treated successfully with prompt administration of oral rehydration solution, while severely dehydrated patients need rapid intravenous fluids alongside ORS and antibiotics. Severe acute watery diarrhoea can be fatal within hours if untreated, and symptoms appear anywhere from 12 hours to five days after infection.
That timeline is the operational point. When death can arrive within hours, the decisive variable is how long it takes a patient to reach rehydration, which is why responses push the treatment point outwards rather than waiting for patients to travel. South Sudan's response has run 19 cholera treatment centres, 88 cholera treatment units and 102 oral rehydration points nationally, alongside 8.6 million oral cholera vaccine doses administered across 46 of 48 targeted counties.
We supply water treatment and storage, so let us be plain about the boundary: for someone who is already sick, ORS and clinical rehydration are what determine survival, not the product in their jerrycan. Health teams own that side of the response, and the CFR is theirs to move.
What does safe water contribute?
Safe water works on the denominator rather than the numerator. WHO states that access to safe water, basic sanitation and hygiene is essential to prevent cholera and other waterborne diseases, and prevention is measured in cases that never happen.
The connection to the fatality rate is indirect but real, and it runs through capacity. Treatment centres, oral rehydration points and clinical staff have a fixed throughput. When incidence outruns that throughput, waiting times lengthen, severe cases present later, and the proportion who die rises. Controlling transmission is therefore not an alternative to treatment access; it is what keeps treatment access from being swamped.
The standards to hold are specific. Sphere sets free residual chlorine at 0.5 mg/L or above after 30 minutes of contact at pH below 8, and 0.2 mg/L or above at the point of delivery, with turbidity at or below 5 NTU, alongside 7.5 to 15 litres per person per day, a water point within 500 metres of dwellings, and queuing under 30 minutes. Sphere sets a minimum of 0.2 mg/L free chlorine at the point of delivery still present 24 hours after treatment.
The field evidence says meeting the tapstand target is not the same as meeting the target in the cup. Research published in the Bulletin of the World Health Organization found that in South Sudan refugee camps, 40 to 58% of households drawing from chlorinated tapstands had no detectable residual chlorine in their stored water, and that standard doses could not reliably hold 0.2 mg/L 24 hours after distribution, with the authors recommending an initial target closer to 1.0 mg/L. Chlorinating the source and then not testing what people actually drink is the most common way a WASH programme records success it did not achieve.
Which lever moves first?
Our view, from the Juba warehouse rather than a modelling exercise: in the first weeks of a flare, treatment access is what moves the case fatality rate, and safe water is what stops the caseload rebuilding over the months that follow. Sequencing them the other way round costs lives, and treating them as competing budget lines is a false choice.
South Sudan's trajectory shows both working together. Weekly cases fell from an average of around 1,000 at the December 2024 peak to 114 in the last week of September 2025, and affected counties fell from 55 to 12, with WHO's Regional Office for Africa estimating the sustained response prevented around 94,000 deaths over two years. The longer-term target is set by the Global Task Force on Cholera Control, whose 2030 roadmap aims for a 90% reduction in cholera deaths.
What has to hold in the supply chain, and for how long?
Longer than most procurement plans assume. South Sudan's outbreak has run past a year, so a pipeline built for a six-week emergency will fail somewhere in month four, usually quietly. Three things tend to break first.
Test consumables before treatment products. DPD tablets and comparators run out faster than anyone forecasts, and once FRC testing stops, the programme is guessing.
Storage and collection containers. Holding a residual for 24 hours depends on covered, narrow-necked containers and clean tanks, not only on the dose added.
The dose itself under turbidity. An Aquatabs 67mg tablet treats 8 to 10 litres of clear water with 30 minutes of contact, so a flood-season switch to turbid sources changes both the product and the quantity you need.
None of that is exotic. It is inventory discipline against a demand curve measured in months, and it is the part of the response an in-country supplier can genuinely be held to. Our WASH product range and our South Sudan operations exist to keep that curve supplied without a re-tender every time the water changes.
Frequently asked questions
What is a good cholera case fatality rate?
WHO's benchmark is that the case fatality rate in treatment centres should remain below 1%. Outbreak-wide rates that include community deaths are usually higher and are not directly comparable.
What was South Sudan's cholera case fatality rate?
South Sudan reported 71,825 suspected cases and 1,194 deaths between 1 January and 17 August 2025, a case fatality rate of 1.7%, across 55 of 80 counties.
Why do people still die from cholera when treatment is simple?
Because many never reach treatment. WHO reports that nearly 50% of reported cholera deaths occur within communities before patients reach health facilities, with delays in accessing care driving elevated fatality rates.
Does safe water reduce the case fatality rate directly?
Not directly. Safe water prevents infections, and WHO describes safe water, sanitation and hygiene as essential to prevent cholera. Its effect on the fatality rate is indirect, by keeping caseloads within the capacity of treatment services.
What chlorine level should a cholera response hold?
Sphere requires 0.5 mg/L free residual chlorine after 30 minutes at pH below 8 and 0.2 mg/L at the point of delivery. Field research in South Sudan camps found standard doses often failed to hold 0.2 mg/L in stored water 24 hours later, so test at the household, not only at the tapstand.
Related reading
Specialized Logistics Solutions is an in-country distributor based in Juba, an authorised distributor for Aquatabs (Medentech/Kersia), P&G Purifier of Water and Oxfam tanks (Butyl Products), and a UNGM-registered vendor (No. 380716). In the 2024-2025 South Sudan cholera response we deployed more than 52 million Aquatabs 67mg tablets in 5,207 boxes, a treatment capacity exceeding 1 billion litres, and distributed 3.28 million P&G Purifier of Water sachets to 27,344 households, which is the kind of sustained volume a year-long outbreak actually consumes. Request a quotation from SLS to build a WASH pipeline sized for months rather than weeks.

Comments